The bill
Innovate Less Lethal to De-Escalate Tax Modernization Act
HR. 4242, 119th Congress — read as touching Firearms & Ammunition.
Sponsored by
Rep. Schweikert, David [R-AZ-1]
ID: S001183
Follow the money
The bill
HR. 4242, 119th Congress — read as touching Firearms & Ammunition.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
30 itemised contributions to this sponsor, pulled from FEC filings.
The alignment
This bill's text tracks the "Environmental Protection Agency" section, p. 458-460 of the Mandate for Leadership.
Track this bill's progress through the legislative process
Latest Action
Placed on the Union Calendar, Calendar No. 407.
February 1, 2026
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Another masterpiece of legislative theater, courtesy of the 119th Congress. Let's dissect this farce and expose the real disease beneath.
**Main Purpose & Objectives:** The "Innovate Less Lethal to De-Escalate Tax Modernization Act" is a mouthful of Orwellian doublespeak. Its primary objective is to exempt certain less-than-lethal projectile devices from firearms and ammunition taxes, as well as the National Firearms Act (NFA). The bill's sponsors claim this will "modernize" the tax code and promote innovation in non-lethal technologies.
**Key Provisions & Changes to Existing Law:** The bill amends Section 4182 of the Internal Revenue Code to exclude less-than-lethal projectile devices from taxation. It also creates a new subsection (d) that defines these devices and outlines the process for determining whether they meet the exemption criteria. The Secretary of the Treasury is tasked with maintaining an annual list of exempt devices.
**Affected Parties & Stakeholders:** The usual suspects are involved: manufacturers, producers, and importers of less-than-lethal projectile devices; law enforcement agencies; and, of course, the gun lobby. Don't be fooled – this bill has nothing to do with "de-escalation" or public safety. It's a giveaway to the firearms industry, plain and simple.
**Potential Impact & Implications:** This bill is a symptom of a deeper disease: the corrupting influence of special interest groups on our legislative process. By exempting these devices from taxation, Congress is essentially subsidizing the development and sale of non-lethal weapons. This will likely lead to increased proliferation of these devices, which could be used for nefarious purposes.
The real motivation behind this bill? Money, power, and ego. The gun lobby wants to expand its market share, while lawmakers want to appease their donors and appear "tough on crime" without actually doing anything meaningful. Meanwhile, the public is left with a watered-down version of gun control that does little to address the root causes of violence.
In conclusion, this bill is a farce, a thinly veiled attempt to line the pockets of special interest groups while pretending to care about public safety. It's a classic case of "legislative lupus" – a disease characterized by chronic dishonesty, corruption, and a complete disregard for the well-being of citizens.
Diagnosis: Terminal stupidity, with a side of cynicism and a dash of greed. Prognosis: Poor. Treatment: None, as our politicians are too busy playing politics to actually address the underlying issues.
Rep. Schweikert, David [R-AZ-1]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No committee contributions found
This bill has 10 cosponsors. Below are their top campaign contributors.
ID: S001211
Top Contributors
10
ID: F000471
Top Contributors
10
ID: F000470
Top Contributors
10
ID: T000478
Top Contributors
10
ID: C001126
Top Contributors
10
ID: C001063
Top Contributors
10
ID: D000230
Top Contributors
10
ID: G000600
Top Contributors
0
No contribution data available
ID: M000317
Top Contributors
10
ID: M001205
Top Contributors
10
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 69 nodes and 45 connections (83 secondary connections hidden)
Total contributions: $221,519
Showing top 20 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 1 helped.
Section 2 exempts certain less-than-lethal projectile devices from firearms and ammunition tax under Section 4182 of the Internal Revenue Code, providing a tax break for manufacturers of such devices. Section 3 further amends the National Firearms Act to exclude these devices, reducing regulatory burden. This benefits firearms industry producers of less-than-lethal weapons.
This bill shows semantic similarity to the following sections of the Project 2025 policy document.AI-enhanced analysis provides detailed alignment ratings.
AI Analysis:
"The bill focuses on tax exemptions for less-than-lethal weapons to encourage innovation and de-escalation, while the Project 2025 EPA section deals with environmental regulations, emissions standards, and permitting reforms. Both touch on modernizing regulations and considering costs/innovation, but their substantive domains are unrelated."
— 426 — Mandate for Leadership: The Conservative Promise l Conduct realistic cost assessments that reflect actual consumer experiences instead of the current unrealistic ones claiming that the program is virtually cost-free. Mobile Source Regulation by the Office of Transportation and Air Quality l Establish GHG car standards under Department of Transportation (DOT) leadership that properly consider cost, choice, safety, and national security. l Review the existing “ramp rate” for car standards to ensure that it is actually achievable. l Include life cycle emissions of electric vehicles and consider all of their environmental impacts. l Restore the position that California’s waiver applies only to California- specific issues like ground-level ozone, not global climate issues. l Ensure that other states can adopt California’s standards only for traditional/criteria pollutants, not greenhouse gases. l Stop the use of the International Civil Aviation Organization (ICAO) to increase standards on airplanes. l Reconsider the Cleaner Trucks Initiative to balance the goal of driving down emissions without creating significant costs or complex burdens on the industry. Air Permitting Reforms for New Source Review (Pre-Construction Per- mits) and Title V (Operating Permits) l Develop reforms to ensure that when a facility improves efficiency within its production process, new permitting requirements are not triggered. l Restore the Trump EPA position on Once-In, Always-In (that major sources can convert to area sources when affiliated emissions standards are met). l Revisit permitting and enforcement assumptions that sources will operate 24 hours a day, 365 days a year; this artificially inflates a source’s potential to emit (PTE), which can result in more stringent permit terms. — 427 — Environmental Protection Agency l Defend the position that petitions to object to Title V should not be used to second-guess previous state decisions. l Clarify the relationship between New Source Review and Title V to ensure that Title V is used only as intended by Congress. CAA Section 11123 l Restore the position that EPA cannot regulate a new pollutant from an already regulated source category without making predicate findings for that new pollutant. l Institute automatic withdrawal of any proposed rule that is not finalized within the statutorily prescribed one-year period. l Revise general implementing regulations for existing source regulatory authority under CAA § 111(d)24 to ensure that EPA gives full meaning to Congress’s direction, including source-specific application, and that the state planning program is flexible, federalist, and deferential to the states. CAA Section 112 (Hazardous Air Pollutants)25 l Unregulated point or non-point source (fugitive emissions) of an already regulated hazardous air pollutant do not require a Maximum Available Control Technology (MACT) standard. l Ensure that Section 112 regulations are harmonized with Section 111 regulations that apply to the same sector/sources. l Ensure that cost-benefit analysis is focused on a regulation’s targeted pollutant and separately identify ancillary or co-benefits. Radiation l Assess and update the agency’s radiation standards so that they align with those of other agencies, including the Nuclear Regulatory Commission, Department of Energy, and Department of Transportation, as well as international standards. l Level-set past, misleading statements regarding radiological risk and reassess the Linear Non-Threshold standard.
AI Analysis:
"The bill focuses on tax exemptions for less-than-lethal projectile devices to promote de-escalation and innovation in law enforcement tools, while the Project 2025 policy excerpt addresses abortion data reporting, gender identity data collection, FDA regulatory reforms, drug shortages, and abortion pills—there is no thematic or policy overlap between the two."
— 456 — Mandate for Leadership: The Conservative Promise abortion providers and whether better prenatal physical, mental, and social care improves infant outcomes and decreases abortion rates, especially among those who are most vulnerable. The Ensuring Accurate and Complete Abortion Data Reporting Act of 20239 would amend title XIX of the Social Security Act and Public Health Service Act to improve the CDC’s abortion reporting mechanisms by requiring states, as a condition of federal Medicaid payments for family planning services, to report streamlined variables in a timely manner. The CDC should immediately end its collection of data on gender identity, which legitimizes the unscientific notion that men can become women (and vice versa) and encourages the phenomenon of ever-multiplying subjective identities. FOOD AND DRUG ADMINISTRATION (FDA) The FDA’s mission includes ensuring the safety and efficacy of drugs, biological products, and medical devices. Federal Laws That Shield Big Pharma from Competition. Because generics generally cost far less than brand-name drugs, consumers begin to save money as soon as a generic product comes on the market. The vast majority are very afford- able with 93 percent of generic products costing $20 or less. Savings would be even higher under proposals that prevent brand-name man- ufacturers from slowing down or impeding the entrance of generic products into the marketplace. Specifically, the FDA should prohibit pharmaceutical companies from purposely sitting on their legally available right to be the first to sell generic versions of their drugs. Additionally, Congress should create legal remedies for generic companies to obtain samples of brand-name products for their generic development efforts and should prohibit meritless “citizen petitions” submitted by manufacturers to delay approval of a generic competitor.10 Approval Process for Laboratory-Developed or Modified Medical Tests. Learning from the failed early COVID-19 testing experience, Congress and the FDA should focus on reforming laws and regulations governing medical tests, especially with respect to laboratory-developed tests. Commercial tests are developed with the intention of being widely marketed, distributed, and used, while laboratory-developed tests are created with the intention of being used solely within one laboratory. A test developed by a lab in accordance with the protocols developed by another lab (non-commercial sharing) currently constitutes a “new” laboratory-developed test because the lab in which it will be used is different from the initial developing lab. To encourage interlab- oratory collaboration and discourage duplicative test creation (and associated regulatory and logistical burdens), the FDA should introduce mechanisms through which laboratory-developed tests can easily be shared with other laboratories with- out the current regulatory burdens.11 — 457 — Department of Health and Human Services The “laboratory-developed tests” category currently encompasses a range of possible tests, many of which would be characterized more appropriately as “lab- oratory-modified tests” because they are not truly novel tests but rather modified versions of existing tests. To avoid stifling innovation and access to medical care, the applicable statutes and regulations should be revised to facilitate greater access to such modified tests.12 Finally, the FDA has long held that it has regulatory authority over such tests, while others have argued that they should be considered clinical services regulated by the Centers for Medicare and Medicaid Services (CMS). The FDA currently has regulatory authority over in vitro diagnostics, and under the Clinical Lab- oratory Improvement Amendments (CLIA),13 the CMS ensures that labs meet analytical validity standards for test methods. Congress, the FDA, and the CMS need to clarify and disentangle overlapping authorities over tests to eliminate regulatory confusion.14 Drug Shortages. The very thin profit margins and the regulatory burdens associated with generic drug manufacturing discourage inventory and capacity investments by manufacturers and contribute to drug shortages. HHS and the FDA should encourage more dependable generic drug manufacturing. The FDA should expand its current pass/fail approach to drug facility inspec- tions into a graded system that recognizes manufacturers that exceed minimum standards by investing in improving production reliability. The FDA should also add facility codes to drug packaging and construct a searchable database that cross-references product codes and facility codes. That would enable wholesalers and pharmacy benefit managers to identify and preference drugs manufactured at more reliable facilities, thus encouraging generic drug manufacturers to compete on reliability as well as on price. For its part, HHS should exempt multi-source generic drugs from requirements to pay rebates to Medicaid and other federally funded health programs, as those provisions penalize new investments in expanding manufacturing capacity when supply is unable to meet demand.15 Additionally, FDA and NIH should promote efficacy trials of new applications for generic drugs, which might include NIH fund- ing such trials or conducting its own. Abortion Pills. Abortion pills pose the single greatest threat to unborn chil- dren in a post-Roe world. The rate of chemical abortion in the U.S. has increased by more than 150 percent in the past decade; more than half of annual abortions in the U.S. are chemical rather than surgical. The abortion pill regimen is typically a two-part process. The first pill, mifepris- tone, causes the death of the unborn child by cutting off the hormone progesterone, which is required to sustain a pregnancy. The second pill, misoprostol, causes con- tractions to induce a delivery of the dead child and uterine contents, usually into a toilet at home. The abortion-pill regimen is currently approved for up to 70 days
AI Analysis:
"The bill focuses on tax exemptions for less-than-lethal projectile devices to promote de-escalation and innovation in non-lethal weapons, while the Project 2025 policy excerpt addresses nuclear waste management, Yucca Mountain, and nuclear deterrence under the Department of Energy and NNSA. There is no thematic or policy overlap between the two."
— 398 — Mandate for Leadership: The Conservative Promise violation of its contractual obligation to take the waste has resulted in the payment of “approximately $10.1 billion in settlements and judgments to contract holders.”99 l Develop new NWF funding and accounting mechanisms that allow licensed nuclear operators to guarantee resources for future nuclear waste disposal while also maintaining control of those resources. l Reconstitute OCRWM. OCRWM, as already established by statute, should be tasked with developing the next steps on Yucca Mountain and nuclear waste management. These steps should include initiating market reforms, including significant amendments to the NWPA, to allow additional industry responsibility for managing waste, market pricing and competition for waste services, and the opportunity for Nevadans to have more partnership involvement with any nuclear facility at Yucca Mountain. l Reestablish, consistent with the Nuclear Waste Policy Act, the position of Director of the Office of Civilian Radioactive Waste Management. Budget Within the Office of Nuclear Energy budget, approximately $100 million is set aside for fuel cycle and waste management activities.100 These funds should be transferred to the newly established OCRWM, which should also be responsible for managing the Nuclear Waste Fund and given access to the fund as necessary to carry out its responsibilities. NATIONAL NUCLEAR SECURITY ADMINISTRATION (NNSA) Mission/Overview NNSA’s primary mission is to provide and maintain a modern, safe, and effective nuclear deterrent for the United States. This includes the design and production of nuclear warheads, their integration with delivery systems, and their safe storage and decommissioning. NNSA’s responsibilities also include developing nuclear reactors for the U.S. Navy and “work[ing] to prevent nuclear weapon proliferation and reduce the threat of nuclear and radiological terrorism around the world.”101 NNSA was established by the NNSA Act, which also defines its authority.102 Needed Reforms The United States, through the NNSA, needs to make the design, development, and deployment of new nuclear warheads a top priority. Existing warheads were — 399 — Department of Energy and Related Commissions designed and built during the Cold War, and the U.S. lacks sufficient plutonium production capabilities.103 Because this process will take time, NNSA and the NNSA Labs need to ensure that existing nuclear warheads are viable and provide an appropriate strategic deterrent. New Policies The expansion of Chinese nuclear forces, the continued nuclear threat from Russia, and active nuclear programs in North Korea, Iran, and elsewhere require NNSA’s recommitment to the nuclear mission. A conservative Adminis- tration should: l Continue to develop new warheads for each branch of the triad (land, sea, and air defenses). If possible, reverse the Biden Administration’s decision to retire the B83 bomb (in order to maintain two aircraft-delivered warheads) and its decision to cancel the submarine-launched cruise missile (SLCM).104 Also undertake an evaluation of the need for nuclear antisubmarine and air defense weapons in light of emerging threats. l Maintain two production sites for plutonium pits (a key element of warhead production) at Los Alamos and Savannah River.105 l Reject ratification of the Comprehensive Test Ban Treaty and indicate a willingness to conduct nuclear tests in response to adversary nuclear developments if necessary. This will require that NNSA be directed to move to immediate test readiness to give the Administration maximum flexibility in responding to adversary actions. l Review all new Navy, Department of Homeland Security, and U.S. Department of Transportation Maritime Administration construction programs. The review should be conducted by the Director of Naval Reactors (DNR) with an eye to the possible inclusion of advanced affordable nuclear reactor technology and extension of DNR authority over these agencies’ nuclear construction programs. l Review the non–national security portfolios at the Los Alamos, Lawrence Livermore, and Sandia labs and identify divestments to focus on nuclear deterrence. Los Alamos, Lawrence Livermore, and Sandia provide unique capabilities for nuclear deterrence, and each lab maintains extensive non–national security research programs and commercial activities.
Showing 3 of 5 policy matches
Policy matches are calculated using a hybrid approach: initial candidates are found using semantic similarity between bill summaries and Project 2025 policy text, then an AI model (Llama 3.1 70B) provides detailed alignment ratings and analysis. Ratings range from 1 (minimal alignment) to 5 (very strong alignment). This analysis does not imply direct causation or intent.